Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      NICE draft guidance on adult hearing loss: Consultation response

      The National Institute for Health and Care Excellence (NICE) has published a draft guidance on the assessment and management of hearing loss in adults for consultation. We would like to know your views in three key areas to include them in our formal response to the draft.

      By: Tahrima Choudhury | 08 December 2017

      The National Institute for Health and Care Excellence (NICE) is an independent organisation, set up by the Government in 1999, to provide national guidance and quality standards on treatments and care for health and social care practitioners and commissioners.

      NICE has published their draft guidance on the assessment and management of hearing loss in adults for consultation. NICE draft guidance can be found here.

      We will be submitting a formal response to the guideline and want to ensure that people with deafness and hearing loss have their views included in our response. We would like to hear your views on recommendations on the following areas:

      Hearing aids: 

      NICE has recommended that hearing aids should be offered to adults whose hearing loss affects their ability to communicate, two hearing aids should be offered to adults with hearing loss in both ears.

      We support this recommendation. There is significant evidence on the improvements to health and well-being from using hearing aids. Research shows that fitting two hearing aids improves speech clarity and reduces listening strain, and enables better localisation of sound.

      Role of GPs in referring to audiology services: 

      NICE has recommended that GPs should refer all adults, regardless of their age who present for the first time with hearing difficulties, or whom hearing difficulties are suspected. 

      We support this recommendation. GPs play a crucial role in the NHS for people with hearing loss, however evidence suggests that often GPs can act as a barrier to people getting help for their hearing loss, by failing to make referrals to audiology services.  

      Removing earwax in primary and community care:  

      NICE has recommended that removal of earwax in primary or community care is offered to adults if it is contributing to hearing loss or other symptoms, or prevents examination of the ear.

      We support this recommendation. Excessive earwax has a negative impact on the ear, hearing and hearing aids. It also affects delivery of services by audiology and ear nose and throat (ENT) departments.  

      Our response to the draft guideline will reviewed by NICE, and changes will be made to the guideline if considered appropriate. The final version is due to be published in May 2018.


      To have your views included in our response,
      please read the guidance and share with us your views by commenting below or emailing Tahrima Choudhury at tahrima.choudhury@hearingloss.org.uk by the 5th of January 2018.

      Recent Posts

      EE partnership brings unbeatable packages

      For the first time ever, selected mobile phones with EE Pay As You Go plans, tailored for people who are deaf or have hearing loss, are available from Action on Hearing Loss.

      By: Brian Burns
      17 October 2018

      REGAIN update on the progress so far and a further opportunity for people with hearing loss to take part in the trial

      A team of researchers and clinicians at UCL’s Ear Institute and the Royal National Throat Nose and Ear Hospital are delighted to announce that the REGAIN trial is approaching its first anniversary and are continuing to recruit people with hearing loss to participate in a ground breaking clinical trial to test the safety and efficacy of a new drug that aims to treat sensorineural hearing loss. The criteria for eligibility to participate in the trial has recently been broadened to include participants with hearing loss of up to 20 years duration (see below for further information).

      By: REGAIN
      16 October 2018

      Preventing hearing loss: the search for treatments

      Medicines like aminoglycoside antibiotics or cisplatin are used to combat life-threatening infections and cancer, respectively, but their use may come at the price of someone’s hearing. Several treatments to prevent the loss of hearing caused by these medicines are currently being developed. Our Translational Research Manager, Dr Carina Santos, tells us more.

      By: Dr Carina Santos
      12 October 2018

      Shining a light on the cochlea

      We fund research across the globe into treatments for hearing loss and tinnitus. One of our newest projects, at the Bionics Institute in Australia, is investigating if we can improve how well cochlear implants work using light.

      By: Dr Tracey Pollard
      11 October 2018

      Recent Posts

      EE partnership brings unbeatable packages

      For the first time ever, selected mobile phones with EE Pay As You Go plans, tailored for people who are deaf or have hearing loss, are available from Action on Hearing Loss.

      By: Brian Burns
      17 October 2018

      REGAIN update on the progress so far and a further opportunity for people with hearing loss to take part in the trial

      A team of researchers and clinicians at UCL’s Ear Institute and the Royal National Throat Nose and Ear Hospital are delighted to announce that the REGAIN trial is approaching its first anniversary and are continuing to recruit people with hearing loss to participate in a ground breaking clinical trial to test the safety and efficacy of a new drug that aims to treat sensorineural hearing loss. The criteria for eligibility to participate in the trial has recently been broadened to include participants with hearing loss of up to 20 years duration (see below for further information).

      By: REGAIN
      16 October 2018

      Preventing hearing loss: the search for treatments

      Medicines like aminoglycoside antibiotics or cisplatin are used to combat life-threatening infections and cancer, respectively, but their use may come at the price of someone’s hearing. Several treatments to prevent the loss of hearing caused by these medicines are currently being developed. Our Translational Research Manager, Dr Carina Santos, tells us more.

      By: Dr Carina Santos
      12 October 2018

      Shining a light on the cochlea

      We fund research across the globe into treatments for hearing loss and tinnitus. One of our newest projects, at the Bionics Institute in Australia, is investigating if we can improve how well cochlear implants work using light.

      By: Dr Tracey Pollard
      11 October 2018

      More like this

      We're really proud of everyone who's a part of Action on Hearing Loss, and hope you'll feel inspired to become a part of our community.​

      We campaign for changes that make life better for people who are confronting deafness, tinnitus and hearing loss.

      Our ears are our organs of hearing and balance. They have three parts: the outer, middle and inner ear.